Since 1996, Innovet Italia is an ¡°innovation company¡± focused on small animal health. The Company¡¯s main goal is to bring scientific innovation emerging from research to particular niche fields of the veterinary market. The philosophy that drives Innovet¡¯s development is ¡°to follow where Nature leads¡±, i.e., to study natural protective body responses and mimic them, rather than ¡°artificially¡± fight the symptoms of the disease.
Based on such a strategic idea, Innovet¡¯s research team discovered and patented a family of bioactive lipid amides (i.e., aliamides, whose parent compound is palmitoylethanolamide, PEA) able to naturally rebalance the hyper-reactive responses of tissues in response to injury. PEA, its micronized and ultramicronized forms and various other congeners, are the main components of Innovet¡¯s innovative products.
Innovet¡¯s commercial effort is mainly focused on the small animal health field, in the market segments of dermatology, orthopedics, oral health, uro-nephrology, behavior and gastroenterology. Recently the Company also entered into the markets of ophthalmology and algology.